Loading...
Sonova Holding AG
SONVF•PNK
Healthcare
Medical - Devices
$290.28
$5.18(1.82%)

Financial performance has remained strong, with revenue growing from $1.76B in Q4 2022 to $1.83B in Q2 2024. Gross profit continued to perform well, with margins at 72% in the latest quarter. Operating income reached $279.20M in Q2 2024, holding a steady 15% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $416.80M. Net income dropped to $208.60M, keeping EPS at $3.49. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan